ReviewPharmaceuticals (Basel, Switzerland)2022

Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19.

Hoda Awad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.